Download Download
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Global Health Leadership: Electing the WHO Director-General
Global HealtH leadersHip: electinG tHe WHo director-General GLOBAL HEALTH centre WORKING PAPER NO. 16 | 2017 Global HealtH leadersHip electinG tHe WHo director-General ilona Kickbusch and austin liu | 1 GLOBAL HEALTH centre WORKING PAPER NO. 16 | 2017 GLOBAL HEALTH CENTRE WORKING PAPER NO. 16 | 2017 Global Health centre Graduate Institute of International and Development Studies Chemin Eugène-Rigot 2 | Case Postale 1672 1211 Geneva 21 – Switzerland Tel + 41 22 908 4558 Fax + 41 22 908 4594 Email [email protected] graduateinstitute.ch/globalhealth 2 | Global HealtH leadersHip: electinG tHe WHo director-General CONTENTS ABBREVIATIONS . 4 ACKNOWLEDGEMENTS . 5 EXECUTIVE SUMMARY . 7 THE GLOBAL HEALTH LEADERSHIP PROJECT. 9 1. HOw do wE UnderstanD global health leadership?. 11 EFFECTIVE LEADERSHIP IN GOVERNING GLOBAL HEALTH. .11 GLOBAL HEALTH LEADERSHIP IN THE CONTEXT. .13 2. A nEw ELECTIOn PROCESS FOR wHO. 16 INCREASED EXPOSURE FOR ALL CANDIDATES. 17 CAMPAIGNING IN THE PUBLIC DOMAIN. .18 MEDIA INVOLVEMENT AND PUBLIC OPINION. 21 A MORE INCLUSIVE AND PARTICIPATORY PROCESS. 21 FAIRNESS AND TRANSPARENCY?. 22 SECRET VOTING: TO PROTECT WHOM FROM WHAT?. 23 DEMOCRATISING GLOBAL POLITICS: GREATER LEGITIMACY AND ACCOUNTABILITY?. 23 3. BROADER IMPLICATIOnS FROM THE ELECTIOn. 25 THE INCREASING POLITICISATION OF WHO’S ELECTION OVER TIME. 25 WHO REFORM: WHERE WE STAND AND WHERE TO GO?. 26 4. IMPROVInG THE wHO ELECTIOn. 27 ENDNOTES. 29 ANNEX: RELEVANT MATERIALS . 35 | 3 GLOBAL HEALTH centre WORKING PAPER NO. 16 | 2017 ABBREVIATIONS AMR Antimicrobial -
World Health Organization Gets First Leader from Africa : Nature News & Comment
NATURE | NEWS World Health Organization gets first leader from Africa Ethiopia’s Tedros Adhanom Ghebreyesus to head agency amid calls for reform. Declan Butler 23 May 2017 Fabrice Coffrini/AFP/Getty Tedros Adhanom Ghebreyesus, from Ethiopia, is the World Health Organization's next director-general. The World Health Organization (WHO) has its first director-general from Africa. Ethiopia’s Tedros Adhanom Ghebreyesus will take the top post at the agency from 1 July — succeeding Margaret Chan — after winning a 23 May vote by WHO member states at the World Health Assembly, their annual gathering in Geneva, Switzerland. Tedros is a public-health expert who has formerly been both a health minister and a foreign minister in Ethiopia’s government, and he will lead the WHO for a 5-year term. He takes the helm troubled times: the WHO’s core budget — its dues from its members — is falling, and it is now dangerously dependent on the voluntary contributions that make up the vast bulk of its spending and often come with strings attached by donors. The agency has also often been criticized for its complex, bureaucratic and ineffective management structure. Chan has spent a decade (two terms) in office. Her leadership was criticized in 2014, when the agency was slow to respond to the Ebola epidemic in West Africa. That prompted several outside reviews and ongoing reforms of ways the organization responds to disease outbreaks. Widespread horse-trading between Related stories Related stories the WHO’s member states was • Clock is ticking for WHO • Clock is ticking for WHO expected during the secret ballot for decision over Taiwan decision over Taiwan the director-general position, at which new voting rules were • The time is ripe to reform • The time is ripe to reform applied. -
Cost, Affordability and Cost-Effectiveness of Strategies To
BMC Public Health BioMed Central Research article Open Access Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence Christine SM Currie1, Katherine Floyd*2, Brian G Williams2 and Christopher Dye2 Address: 1School of Mathematics, University of Southampton, Southampton, SO17 1BJ, UK and 2HIV/AIDS, Tuberculosis and Malaria cluster, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland Email: Christine SM Currie - [email protected]; Katherine Floyd* - [email protected]; Brian G Williams - [email protected]; Christopher Dye - [email protected] * Corresponding author Published: 12 December 2005 Received: 07 April 2005 Accepted: 12 December 2005 BMC Public Health 2005, 5:130 doi:10.1186/1471-2458-5-130 This article is available from: http://www.biomedcentral.com/1471-2458/5/130 © 2005 Currie et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The HIV epidemic has caused a dramatic increase in tuberculosis (TB) in East and southern Africa. Several strategies have the potential to reduce the burden of TB in high HIV prevalence settings, and cost and cost-effectiveness analyses can help to prioritize them when budget constraints exist. However, published cost and cost-effectiveness studies are limited. Methods: Our objective was to compare the cost, affordability and cost-effectiveness of seven strategies for reducing the burden of TB in countries with high HIV prevalence. -
Światowa Organizacja Zdrowia
M. Vasiliew, Student N. Kostynska, doradca językowy Żytomierski Instytut Medyczny ŚWIATOWA ORGANIZACJA ZDROWIA Światowa Organizacja Zdrowia wyspecjalizowana agencja Organizacji Narodów Zjednoczonych, jest główną organizacją międzynarodową, zajmuąca się problemami zdrowia. Jej siedzibą jest Genewa. W 1946 r. ONZ zwołała Międzynarodową Konferencję Zdrowia w Nowym Jorku, gdzie 61 krajów ratyfikowało konwencję WHO. W roku 1948 w liczbie już 88 członków ratyfikowano powstanie WHO. Do WHO należą obecnie 194 kraje. Głównym obchodem, organizowanym przez WHO co roku w dniu 7 kwietnia, jest Światowy Dzień Zdrowia. Zadaniem WHO jest: działanie na rzecz zwiększenia współpracy między państwami w dziedzinie ochrony zdrowia, zwalczania epidemii chorób zakaźnych, ustalanie norm dotyczących składu lekarstw i jakości żywności, dąży również do zapewnienia opieki medycznej ludności świata oraz zmniejszenia śmiertelności niemowląt. [6, c.3] Do największych sukcesów tej organizacji należy zwalczanie epidemii groźnych chorób, takich jak: gruźlica, malaria, cholera czy dżuma poprzez masowe szczepienie. WHO walczy także z AIDS. Główne organy Światowej Organizacji Zdrowia to: Sekretariat na czele z dyrektorem generalnym, Światowe Zgromadzenie Zdrowia, Rada Wykonawcza, Komitety Regionalne. Działalność WHO jest wspomagana przez 6 biur regionalnych oraz 147 biur krajowych i łącznikowych. Oprócz biura stałego mieszczącego się w Genewie, WHO posiada regionalne biura: Afryka – Brazzaville, dla obu Ameryk – Waszyngton, dla płd.-wsch. Azji – New Delhi, dla Europy Kopenhaga, dla regionu śródziemnomorskiego – Каir dla regionu zach. Pacyfiku – Manila. Władzą naczelną WHO jest Światowe Zgromadzenie Zdrowia, które stanowią przedstawiciele wszystkich krajów członkowskich, które zbiera się raz do roku w Genewie. Zgromadzenie wybiera na okres 3 lat Komitet Wykonawczy, w którego skład wchodzi 34 ekspertów w dziedzinie zdrowia proponowanych przez kraje członkowskie. Zadaniem Komitetu jest realizacja decyzji i wytycznych Zgromadzenia. -
Recent News from WHO
WHO News ensure that food of animal origin does influenza. Here, we have focused both of setting food safety standards based not bring with it unwanted and unex- on occupational and food-safety aspects, on independent scientific advice. pected consequences such as the occur- promoting simple messages to avoid WHO’s collaboration with the Food rence of resistance to antimicrobials or transmission of the virus by following and Agriculture Organization and other antibiotics that we use to treat disease sensible rules for contact with poultry UN agencies in establishing these food in humans. This is a result of the use and its slaughter and preparation. standards has helped to improve the of antibiotics in animal fodder, which lives of people worldwide and to facili- contributes to the emergence of anti- Q: How effective is the Codex Alimen- tate international trade in food. We need microbial resistance in pathogens, such tarius for fighting foodborne disease? to work towards a greater use of existing as Salmonella and Campylobacter, that A: Despite some of its weaknesses, trade mechanisms, such as aid for trade, are transmitted to humans via contami- such as the slow and cumbersome to help developing countries improve nated meat. And we should not forget administrative procedures, the Codex risk assessment and risk management our preventive work related to avian Alimentarius is an important means systems for food safety. O Recent news from WHO • Dr Margaret Chan of China, 59, was appointed as WHO’s new director-general on 9 November, following the untimely death of Dr Lee Jong-wook in May 2006. -
Research Paper 121 November 2020
Research Paper 121 November 2020 The World Health Organization Reforms in the Time of COVID-19 Germán Velásquez Chemin du Champ d’Anier 17 PO Box 228, 1211 Geneva 19 Switzerland Telephone : (41 22) 791 8050 Email : [email protected] website: http://www.southcentre.int ISSN 1819-6926 RESEARCH PAPER 121 THE WORLD HEALTH ORGANIZATION REFORMS IN THE TIME OF COVID-19 Germán Velásquez1 SOUTH CENTRE NOVEMBER 2020 1 Dr. Germán Velásquez is Special Adviser, Policy and Health at the South Centre, Geneva. The author thanks Dr. Carlos Correa and Dr. Viviana Muñoz for their valuable comments. The views presented in this paper are however the sole responsibility of the author. SOUTH CENTRE In August 1995 the South Centre was established as a permanent intergovernmental organization. It is composed of and accountable to developing country Member States. It conducts policy-oriented research on key policy development issues, and supports developing countries to effectively participate in international negotiating processes that are relevant to the achievement of the Sustainable Development Goals (SDGs). The Centre also provides technical assistance and capacity building in areas covered by its work program. On the understanding that achieving the SDGs, particularly poverty eradication, requires national policies and an international regime that supports and does not undermine development efforts, the Centre promotes the unity of the South while recognizing the diversity of national interests and priorities. NOTE Readers are encouraged to quote or reproduce the contents of this Research Paper for their own use, but are requested to grant due acknowledgement to the South Centre and to send a copy of the publication in which such quote or reproduction appears to the South Centre. -
28Th Meeting of Ministers of Health, Bangkok, Thailand, 7 September
Report of the Twenty-eighth Meeting f Ministers of Health of Countries f the South-East Asia Region Thailand, 7 September 201 0 4 SEA-HM Meet-28 Distribution: General Report of the Twenty-eighth Meeting of Ministers of Health of Countries of the South-East Asia Region Bangkok, Thailand, 7 September 2010 © World Health Organization 2010 All rights reserved. Requests for publications, or for permission to repro- duce or translate WHO publications, whether for sale or for noncommercial distribution, can be obtained from Publishing and Sales, World Health Or- ganization, Regional Office for South-East Asia, Indraprastha Estate, Ma- hatma Gandhi Marg, New Delhi-110 002, India (fax: +91-11-23370197; e-mail: publications@ searo.who.int). The designations employed and the presentation of the material in this pub- lication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not men- tioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organiza- tion to verify the information contained in this publication. -
Press Release on Ending Polio
Press Release Embargoed until Thursday, 27 September 2012 12:30 p.m., New York time Global Luminaries Unite to Issue Urgent Call for a Polio-Free World New and Existing Donors Underscore Once-in-a-Generation Opportunity to End Polio Forever UNITED NATIONS, 27 September 2012 – In a display of solidarity, leaders from around the world today vowed to capitalize on progress achieved this year and to step up the fight to eradicate polio. Heads of state from Afghanistan, Nigeria and Pakistan stood alongside donor government officials and new donors from the public and private sector to outline what is needed to stamp out this disease forever: long-term commitment of resources, applying innovative best practices, and continued leadership and accountability at all levels of government in the endemic countries. “This decisive moment is a matter of health and justice. Every child should have the right to start life with equal protection from this disease. That’s why I have made eradicating polio a top priority for my second term as Secretary-General,” said UN Secretary-General Ban Ki-moon. Polio is a vaccine-preventable disease that is more than 99 percent eliminated from the world. Today, there are the fewest number of polio cases in the fewest districts in the fewest countries than at any time in history. In 1988, when the global fight against polio began, there were 125 countries where polio raged. Today, there are only three: Nigeria, Pakistan and Afghanistan. India, long-regarded as the nation facing the greatest challenges to eradication, has been polio-free for more than 18 months. -
Universal Health Coverage: Only About Financial Protection?
B1 | UNIVERSAL HEALTH COVERAGE: ONLY ABOUT FINANCIAL PROTECTION? The struggle for health is partly about the struggle for decent healthcare and for functioning health systems that care for sick people and contribute to improving population health There is much at stake in health system reform, and not just the provision of decent healthcare The field is intensely contested among various parties (providers, suppliers, insurers and so on) who have a powerful economic interest in the outcomes of the debate Such interest groups project a policy narrative that proposes ‘public interest’ logic to their preferred pathways while obscuring their vested interests Getting a clear picture of the substantive policy issues and choices requires penetrating the fog and reinterpreting the rhetoric The pressures for health system reform arise in the systemic problems perceived by different players: community concerns about quality and access, Image B1.1 Community mobilisation can shape health systems: Women in India demonstrate against privatisation of health services (Sulakshana Nandi) GHW5 1st proof.indd 73 09/08/2017 16:50 74 | section b:1 the grievances of providers regarding conditions and remuneration, and cor- porate concerns about barriers to profitable engagement These pressures are variously expressed through community mobilization, professional advocacy, research findings, corporate lobbying and bureaucratic task groups Whether or not change takes place depends on the stability of existing structures and the feasibility of and support for available -
REFORM, RESILIENCE, and GLOBAL HEALTH GOVERNANCE Sophie Harman
Briefing 17 May 2014 IS TIME UP FOR WHO? REFORM, RESILIENCE, AND GLOBAL HEALTH GOVERNANCE Sophie Harman The World Health Organization (WHO) provides a litmus test for reforming the UN development system (UNDS). While often praised as among the most competent and essential, it occupies an increasingly crowded institutional terrain. It must emphasize its comparative advantages. The May 2014 Sixty-Seventh World Health Assembly comes at a and progressive rather than absolute universalism; and between its critical point in the history of WHO, which is mid-way through a regional bases for operations and the need to have a common global reform agenda initiated by Director-General Margaret Chan in agenda. These three tensions have waxed and waned in response 2011 to review its programs, governance, and management. The to changes in the international system and WHO’s development WHO in many respects provides a test-case for how members of within it. Tensions in large international organizations will always the UN system can adapt or wither in the contemporary era of exist; the issue is how such tensions are managed. With regard to partnerships, new sources of financing, and the crowded terrain. WHO, these tensions are used not as evidence of a thriving Few institutions have been subject to such consistent calls for institution that is reflective and responsive to the context in which reform in the midst of a seeming redundancy of organizations it works but as one that is in need of transformation. devoted to health. As the plethora of new institutions are less responsive than commonly thought, this briefing reviews possible WHO’s bureaucracy has not helped diffuse the notion that it is an reforms WHO and the different arguments about what WHO would institution in need of reform. -
Establishment & Lineage Dynamics of the SARS-Cov-2 Epidemic in the UK
medRxiv preprint doi: https://doi.org/10.1101/2020.10.23.20218446; this version posted October 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Establishment & lineage dynamics of the SARS-CoV-2 epidemic in the UK Louis du Plessis†1, John T. McCrone†2, Alexander E. Zarebski†1, Verity Hill†2, Christopher Ruis†3,4, Bernardo Gutierrez1,5, Jayna Raghwani1, Jordan Ashworth2, Rachel Colquhoun2, Thomas R. Connor6,7, Nuno R. Faria1,8, Ben Jackson2, Nicholas J. Loman9, Áine O’Toole2, Samuel M. Nicholls9, Kris V. Parag8, Emily Scher2, Tetyana I. Vasylyeva1, Erik M. Volz8, Alexander Watts12,13, Isaac I. Bogoch10,11, Kamran Khan10,12,13, the COVID-19 Genomics UK (COG-UK) Consortium+,14, David M. Aanensen15,16, Moritz U. G. Kraemer‡1, Andrew Rambaut*‡2, Oliver G. Pybus*‡1,17 1 Department of Zoology, University of Oxford, Oxford, UK. 2 Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK. 3 Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK. 4 Department of Veterinary Medicine, University of Cambridge, Cambridge, UK. 5 School of Biological and Environmental Sciences, Universidad San Francisco de Quito USFQ, Quito, Ecuador. 6 School of Biosciences, Cardiff University, UK. 7 Pathogen Genomics Unit, Public Health Wales NHS Trust, UK. 8 MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, UK. 9 Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK. -
Anti-Tuberculosis
WHO/CDS/TB/2000.278 Anti-tuberculosis Drug Resistance in the World Anti-tuberculosis Communicable Diseases SURVEILLANCE GLOBALPROJECT ON ANTI-TUBERCULOSIS DRUG RESISTANCE THE WHO/IUATLD WORLD HEALTH ORGANIZATION ANTI-TUBERCULOSIS 20, avenue Appia CH-1211 Geneva 27 SWITZERLAND Telephone 41 22 791 2708 Facsimile 41 22 791 4268 Report No.2 Prevalence and Trends Prevalence and Trends Report No.2 THE WHO/IUATLD GLOBAL PROJECT ON ANTI-TUBERCULOSIS DRUG RESISTANCE SURVEILLANCE COMMUNICABLE DISEASES WORLD HEALTH ORGANIZATION WHO/CDS/TB/2000.278 Distr.: General Original: English ANTI-TUBERCULOSIS DRUG RESISTANCE IN THE WORLD Report No. 2 Prevalence and Trends The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance Communicable Diseases World Health Organization Geneva 2000 © World Health Organization, 2000 This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced or translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes. The views expressed in documents by named authors are solely the responsibility of those au- thors. WRITING COMMITTEE • Marcos A. Espinal, M.D., Dr.P.H., M.P.H., Communicable Diseases Surveillance & Response and Communicable Diseases Control, Prevention & Eradication, World Health Organization (WHO), Geneva, Switzerland; • Lone Simonsen, Ph.D., Communicable Diseases Surveillance & Response, WHO, Geneva, Switzerland; • Adalbert Laszlo, Ph.D., Laboratory Centre for Disease Control, Ottawa, Canada; International Union Against Tuberculosis and Lung Disease (IUATLD); • Fadila Boulahbal, Ph.D., Institut Pasteur, Alger, Algeria; • Sang Jae Kim, Sc.D., Korean Institute of Tuberculosis, Seoul, Republic of Korea; • Ana Reniero, Ph.D., Instituto Panamericano de Protección de Alimentos y Zoonosis, Buenos Aires, Argentina; • Sven Hoffner, Ph.D., Swedish Institute for Infectious Disease Control, Stockholm, Sweden; • Hans L.